These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37713615)

  • 1. Multidisciplinary cardiogenic shock team approach improves the long-term outcomes of patients suffering from refractory cardiogenic shock treated with short-term mechanical circulatory support.
    Hérion FX; Beurton A; Oddos C; Nubret K; Aguerreche C; Quessard A; Faure M; Gerbaud E; Pernot M; Imbault J; Ouattara A
    Eur Heart J Acute Cardiovasc Care; 2023 Dec; 12(12):821-830. PubMed ID: 37713615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridge to durable left ventricular assist device for refractory cardiogenic shock.
    Yoshioka D; Takayama H; Garan AR; Topkara VK; Han J; Li B; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    J Thorac Cardiovasc Surg; 2017 Apr; 153(4):752-762.e5. PubMed ID: 27988030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.
    Takeda K; Garan AR; Topkara VK; Kirtane AJ; Karmpaliotis D; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takayama H
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):591-596. PubMed ID: 27818380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era.
    Takayama H; Truby L; Koekort M; Uriel N; Colombo P; Mancini DM; Jorde UP; Naka Y
    J Heart Lung Transplant; 2013 Jan; 32(1):106-11. PubMed ID: 23260710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock.
    Tokunaga C; Iguchi A; Nakajima H; Chubachi F; Hori Y; Takazawa A; Hayashi J; Asakura T; Yoshitake A
    BMC Cardiovasc Disord; 2022 Feb; 22(1):54. PubMed ID: 35172726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative Care Consultation in Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Retrospective Cohort Study.
    Nakagawa S; Garan AR; Takeda K; Takayama H; Topkara VK; Yuzefpolskaya M; Yuill L; Lin SX; Colombo PC; Naka Y; Blinderman CD
    J Palliat Med; 2019 Apr; 22(4):432-436. PubMed ID: 30615561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.
    Garan AR; Eckhardt C; Takeda K; Topkara VK; Clerkin K; Fried J; Masoumi A; Demmer RT; Trinh P; Yuzefpolskaya M; Naka Y; Burkhoff D; Kirtane A; Colombo PC; Takayama H
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):755-765. PubMed ID: 29094607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary surgical ventricular assist device for treatment of acute myocardial infarction and refractory cardiogenic shock in the percutaneous device era.
    Singh SK; Witer L; Kaku Y; Masoumi A; Fried JA; Yuzefpolskaya M; Colombo PC; Sayer G; Uriel N; Naka Y; Takayama H; Takeda K
    J Artif Organs; 2021 Jun; 24(2):199-206. PubMed ID: 33459913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry): Observational and Retrospective Study.
    Tehrani B; Truesdell A; Singh R; Murphy C; Saulino P
    JMIR Res Protoc; 2018 Jun; 7(6):e160. PubMed ID: 29954728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with temporary right ventricular mechanical circulatory support.
    Bhama JK; Bansal U; Winger DG; Teuteberg JJ; Bermudez C; Kormos RL; Bansal A
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1885-1891. PubMed ID: 29861112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
    den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO.
    Karami M; den Uil CA; Ouweneel DM; Scholte NT; Engström AE; Akin S; Lagrand WK; Vlaar AP; Jewbali LS; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):164-172. PubMed ID: 31353918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
    Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
    Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A team-based approach to patients in cardiogenic shock.
    Doll JA; Ohman EM; Patel MR; Milano CA; Rogers JG; Wohns DH; Kapur NK; Rao SV
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):424-33. PubMed ID: 26526563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.
    Guenther S; Theiss HD; Fischer M; Sattler S; Peterss S; Born F; Pichlmaier M; Massberg S; Hagl C; Khaladj N
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):283-91. PubMed ID: 24336784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST-segment elevation myocardial infarction and refractory cardiogenic shock.
    Huang CC; Hsu JC; Wu YW; Ke SR; Huang JH; Chiu KM; Liao PC
    Int J Cardiol; 2018 Oct; 269():45-50. PubMed ID: 30077527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.
    Takayama H; Soni L; Kalesan B; Truby LK; Ota T; Cedola S; Khalpey Z; Uriel N; Colombo P; Mancini DM; Jorde UP; Naka Y
    Circ Heart Fail; 2014 Sep; 7(5):799-806. PubMed ID: 25027874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock.
    Pawale A; Schwartz Y; Itagaki S; Pinney S; Adams DH; Anyanwu AC
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1059-1068. PubMed ID: 29274911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.